Company
Headquarters: Zhunan, Taiwan
TW$1.60 Billion
TWD as of Jan. 1, 2024
US$52.1 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Bioptik Technology Incorporation researches, develops, produces, and sells medical devices and reagents in Taiwan and internationally. The company offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. It also provides skin care products and dietary supplements, as well as biodiesel products. The company was founded in 1999 and is headquartered in Zhunan, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Bioptik Technology InCorp has the following listings and related stock indices.
Stock: TWSE: 4161 wb_incandescent